Navigation Links
Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders
Date:12/10/2012

disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company.  Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.

About Isis Pharmaceuticals, Inc.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO™, in the United States and Europe following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at http://www.isispharm.com/.

Biogen Idec Safe Harbor Statement
This press release contains forward-looking statements, including statements about product development and commercialization. These forward-looking statements may be accompanied by such words as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "will" and other words and terms of similar meaning. You should not place undue reliance on these statements. Drug development and commercialization involve a high degree of risk. Factors which could cause actual results to differ materially from current expectations include the risk that adverse safety events may occur, regulatory authorities may require additional information or may fail to approve any potential new therapy, product reimbursement may be limited or unavailable, there may be problems with manufacturing processes, intellect
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 Sequent Medical, Inc. announced today that ... Layer") family of WEB ® Aneurysm Embolization Devices, ... models in select neurovascular centers in Europe.  The SL ... will enable physicians to treat a broader range of ... configurations are made possible by further advancement of Sequent ...
(Date:5/20/2013)... ALISO VIEJO , Kalifornien, 20. Mai ... heute bekannt, dass das Unternehmen die CE-Kennzeichnung ... Implantate zur Embolisation von Aneurysmen erhalten hat. ... in Europa bereits mit der kontrollierten Einführung ... Profil bietet die SL-Produktfamilie auch ein verbessertes ...
(Date:5/20/2013)... , May 20, 2013   Life Technologies ... that its Applied Biosystems™ 3500 Dx and 3500xL Dx ... for Protection against Health Risks in Mexico ... major extension of Life Technologies, capabilities to serve the ... with Sanger -based solutions.  ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3
... 2012 Reportlinker.com announces that a new ... catalogue: , Pharmaceutical M&A in ... http://www.reportlinker.com/p0760637/Pharmaceutical-MA-in-the-Asia-Pacific-Region.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical Introduction ... developed markets, prompted by generic erosion of ...
... /PRNewswire-iReach/ -- Global Information, Inc. (GII) is pleased to ... Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" ... The Insulin Delivery Devices Market is Set to ... by 2017 GlobalData estimated the global ...
Cached Medicine Technology:Pharmaceutical M&A in the Asia Pacific Region 2Pharmaceutical M&A in the Asia Pacific Region 3Pharmaceutical M&A in the Asia Pacific Region 4Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 2Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 3Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 4
(Date:5/20/2013)... The Multiple System Atrophy Coalition (formerly ... its new Multiple System Atrophy (MSA) Research Grant ... MSA Coalition’s grass roots fundraising has grown and enabled ... support to now include education, advocacy and research funding ... by The Coalition go directly into a dedicated MSA ...
(Date:5/20/2013)... Gilman Law LLP, a leading pharmacy law and ... troubled by a new study that reveals that pancreatic ... diabetes drugs are growing. The analysis, conducted by ... 71 Byetta pancreatic cancer reports had been made to ... June 30, 2012. Overall, Byetta and other ...
(Date:5/20/2013)... Sporturf, an international manufacturer and builder of ... the Midwest with the opening of the company’s third ... Midwest is under the leadership of President Craig Shonk, ... , “This strategic move opens up a ... noted Shonk. “Bringing an ISO manufacturer and a Midwest-based ...
(Date:5/20/2013)... Plains, NY (PRWEB) May 20, 2013 ... firm of Levy Phillips & Konigsberg LLP ... Street in White Plains, New York. LPK will better ... in the Hudson Valley, including Westchester, Putnam, Rockland, Orange, ... helping families affected by asbestos-related diseases throughout New York, ...
(Date:5/20/2013)... VA (PRWEB) May 20, 2013 Orthopaedic ... successfully performed a procedure using SpineFrontier’s FacetFuse Screw System ... System. The operation took place on Tuesday, April ... Newport News, VA. The surgery was a facet ... year-old, female patient. , Dr. Carlson described the case, ...
Breaking Medicine News(10 mins):Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
... Now Available on Online Community to Facilitate Collaboration ... BEACH, Fla., May 8 With a growing ... short weeks since launch, e-Zassi.com has added an ... participants involved in the discovery, development and commercialization ...
... York City Raises Money for STAR (TM) ... Charcot-Marie-Tooth Association,s second annual "Honor a Star. Be a Star." ... achievement raised a record amount of over $350,000 at the ... Proceeds earned from event sponsorship, ticket sales and auction items ...
... One Global Health Threat"WASHINGTON, May 8 Today, HIV ... of Human Virology at the University of Maryland ... of the World Foundation for AIDS Research and Prevention, ... six objectives to end the HIV/AIDS pandemic. They ...
... -- Mindray Medical,International Limited (NYSE: MR ... devices worldwide announced today it filed with the,Securities ... 20-F that included,audited financial statements for the year ... Annual Report on Form 20-F is available online,at ...
... part of the Elekta Group, has been selected to ... the 2009 American Society of Clinical Oncology,s (ASCO) Annual ... County Convention Center, in Orlando, Florida. Chosen according to ... third consecutive year Impac Software ...
... May 8, 2009 AMERIGROUP Corporation (NYSE: ... the Deutsche Bank 34th Annual Healthcare Conference on May 18 ... Monday, May 18 at 2:25pm Eastern Time, can be accessed ... the investors, page. A replay will be available for 30 ...
Cached Medicine News:Health News:New Advanced Search and Matching Function Drives e-Zassi.com's Enhanced Functionality 2Health News:Charcot-Marie-Tooth Association's 'Honor a Star. Be a Star.' Gala Generates Over $350,000 for CMT Research 2Health News:A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier 2Health News:A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier 3Health News:Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission 2Health News:Impac Software Selected to Present at the Electronic Health Records Lab During 2009 ASCO Annual Meeting 2
Steroid-eluting, screw-in pacing lead...
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
The Guidant Fineline II EZ Sterox with protective capsule is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
... a low profile implantable bipolar fixed ... of either the atrium or the ... with a screwdriver shape stylet which ... The ring tip and fixation screw ...
Medicine Products: